Complexa Stock

complexarx.comBioTechFounded: 1900Funding to Date: $91.54MM

Complexa is a clinical stage biopharmaceutical company focused on transforming the treatment of fibrosis and inflammatory diseases.

Register for Details

For more details on financing and valuation for Complexa, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Joshua Tarnoff
Chief Executive Officer, President & Board Member
Bruce Freeman Ph.D
Co-Founder & Co-Founding Scientist
Meg Tarpey MD
Founding Scientist
Theodore Danoff Ph.D
Chief Medical Officer
Francisco Salva
Board Member, President & Chief Executive Officer
Raymond Miller JD
Co-Founder
David Mott
Chairman of the Board of Directors

Board Members

Barbara Dalton Ph.D
Pfizer Ventures
Bernardus Machielse
David Mott
Gilles Nob├ęcourt
Andera Partners
I. Wistar Morris III
Joshua Tarnoff
Kenji Harada Ph.D
Jafco
Sara Nayeem MD
New Enterprise Associates

Other companies like Complexa in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM

News

Complexa Inc. today announced the appointment of Theodore (Theo) Danoff, MD, PhD, as Chief Medical Officer. Dr. Danoff formerly served as Chief Medica